MedPath

Nizatidine

Nizatidine Capsules USP

Approved
Approval ID

1d6161e3-2ddb-5446-e054-00144ff8d46c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 15, 2015

Manufacturers
FDA

Medsource Pharmaceuticals

DUNS: 833685915

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nizatidine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code45865-374
Application NumberANDA090618
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nizatidine
Product Specifications
Route of AdministrationORAL
Effective DateAugust 15, 2015
FDA Product Classification

INGREDIENTS (9)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
NIZATIDINEActive
Quantity: 150 mg in 1 1
Code: P41PML4GHR
Classification: ACTIB
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Nizatidine - FDA Drug Approval Details